Drug intelligence / Profile preview

lyophilised plasma

Development stage
Unknown
Lead developer
JKU Linz
Modality
Recombinant Proteins and Enzymes
Administration
Intravenous
01

Overview

Lyophilised plasma is a freeze-dried blood product derived from human plasma, designed for rapid reconstitution and use in emergency medical settings. Developed by the Red Cross of Upper Austria (Blutzentrale Linz) in collaboration with Johannes Kepler University Linz, this specific formulation is primarily indicated for the treatment of haemorrhagic shock and trauma-induced coagulopathy. Unlike fresh frozen plasma (FFP), lyophilised plasma can be stored at room temperature and does not require a cold chain, making it highly suitable for pre-hospital, remote, and military trauma care. It contains a full complement of human coagulation factors, albumin, and other plasma proteins, which work to restore blood volume and promote haemostasis. The product undergoes pathogen inactivation (typically using solvent/detergent treatment) to ensure safety and is reconstituted with sterile water immediately before intravenous administration.

Brand names
Lyo-Plasma
Other names
Freeze-dried plasmaFDPLyophilized plasma
02

Targets

F (Coagulation factors)

Beyond the preview

Go deeper on lyophilised plasma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lyophilised plasma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call